HTH-01-091
HTH-01-091 is a potent and selective maternal embryonic leucine zipper kinase (MELK) inhibitor, with an IC50 of 10.5 nM. HTH-01-091 also inhibits PIM1/2/3, RIPK2, DYRK3, smMLCK and CLK2. HTH-01-091 can be uesd for breast cancer research[1].
Product Specifications
CAS Number
[2000209-42-5]
UNSPSC
12352005
Target
CDK; DYRK; GSK-3; MELK; mTOR; Pim; RIP kinase
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; JAK/STAT Signaling; PI3K/Akt/mTOR; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hth-01-091.html
Purity
98.64
Solubility
DMSO : 12.5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C1N([C@H]2CC[C@H](CN(C)C)CC2)C3=C(CN1)C=NC4=CC=C(C5=CC(Cl)=C(O)C(Cl)=C5)C=C34
Molecular Formula
C26H28Cl2N4O2
Molecular Weight
499.43
References & Citations
[1]Huang HT, et al. MELK is not necessary for the proliferation of basal-like breast cancer cells. Elife. 2017 Sep 19;6:e26693.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK7; DYRK4; mTOR; PIM1; PIM2; PIM3; RIPK2
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![HBS1L Mouse Monoclonal Antibody [Clone ID: LBI1A7]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
